BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bickel M, Gossel M, Geisen K, Jaehne G, Lang HJ, Rosenburg R, Sandow J. Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats. Int J Obes 2004;28:211-21. [DOI: 10.1038/sj.ijo.0802540] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Fong TM. Advances in anti-obesity therapeutics. Expert Opin Investig Drugs 2005;14:243-50. [PMID: 15833056 DOI: 10.1517/13543784.14.3.243] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
2 Mancini MC, Halpern A. Investigational therapies in the treatment of obesity. Expert Opinion on Investigational Drugs 2006;15:897-915. [DOI: 10.1517/13543784.15.8.897] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
3 Suder A. Socioeconomic and lifestyle determinants of body fat distribution in young working males from Cracow, Poland. Am J Hum Biol 2008;20:100-9. [DOI: 10.1002/ajhb.20687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Ortmann S, Kampe J, Gossel M, Bickel M, Geisen K, Jähne G, Lang HJ, Klaus S. The Novel Antiobesic HMR1426 Reduces Food Intake without Affecting Energy Expenditure in Rats. Obesity Research 2004;12:1290-7. [DOI: 10.1038/oby.2004.163] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]